CIK 0001563880
- Non-accelerated filer
- Smaller reporting company
Trevi Therapeutics, Inc.
Sign in to watch- Ticker
- TRVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450834299
- Phone
- +1 203-304-2499
- Business address
- 195 CHURCH STREET, 16TH FLOOR, NEW HAVEN, CT, 06510
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $595,806
- in 1 filing, $596K under 10b5-1 plans
Net −$595,806. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 6 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-11 | Chang Carmen 10% owner | Purchase | +2,631,578 | $1.90 | $5.0M | 10,421,428 |
| 2022-04-11 | Chang Carmen 10% owner | Purchase | +948,948 | $1.90 | $1.8M | 948,948 |
| 2022-04-11 | Chang Carmen 10% owner | Purchase · Pre-Funded Warrants | +3,000,000 | $1.90 | $5.7M | 3,000,000 |
| 2022-04-11 | Behbahani Ali 10% owner | Purchase | +2,631,578 | $1.90 | $5.0M | 10,421,428 |
| 2022-04-11 | Behbahani Ali 10% owner | Purchase | +948,948 | $1.90 | $1.8M | 948,948 |
| 2022-04-11 | Behbahani Ali 10% owner | Purchase · Pre-Funded Warrants | +3,000,000 | $1.90 | $5.7M | 3,000,000 |
| 2022-04-11 | BASKETT FOREST 10% owner | Purchase | +2,631,578 | $1.90 | $5.0M | 10,421,428 |
| 2022-04-11 | New Enterprise Associates 16, L.P. 10% owner | Purchase | +2,631,578 | $1.90 | $5.0M | 10,421,428 |
| 2022-02-14 | GOOD JENNIFER L President & CEO | Grant or award · Stock Option (right to buy) | +275,000 | 275,000 | ||
| 2022-02-14 | GOOD JENNIFER L President & CEO | Grant or award · Stock Option (right to buy) | +275,000 | 275,000 | ||
| 2022-02-11 | SCIASCIA THOMAS Chief Medical Officer | Grant or award · Stock Option (right to buy) | +110,000 | 110,000 | ||
| 2022-02-11 | Forbes William P Chief Development Officer | Grant or award · Stock Option (right to buy) | +137,500 | 137,500 | ||
| 2022-02-11 | SCIASCIA THOMAS Chief Medical Officer | Grant or award · Stock Option (right to buy) | +110,000 | 110,000 | ||
| 2022-02-11 | Galletta Christopher | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2022-02-11 | Delfini Lisa Chief Financial Officer | Grant or award · Stock Option (right to buy) | +110,000 | 110,000 | ||
| 2022-02-11 | Forbes William P Chief Development Officer | Grant or award · Stock Option (right to buy) | +137,500 | 137,500 | ||
| 2021-10-18 | Walker Paul Edward 10% owner | Purchase | +1,851,852 | 7,789,850 | ||
| 2021-10-18 | Walker Paul Edward 10% owner | Purchase · 3.5-Year Common Stock Warrant | +1,851,852 | 1,851,852 | ||
| 2021-10-18 | Walker Paul Edward 10% owner | Purchase · 7-Year Common Stock Warrant | +1,851,852 | 1,851,852 | ||
| 2021-10-18 | Sonsini Peter W. 10% owner | Purchase | +1,851,852 | 7,789,850 |
Page 11 of 21 · 419 trades